About
About Qingdao Vland Biotech INC
Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, food probiotics, environmental microorganisms, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was founded in 2005 and is headquartered in Qingdao, China.
Research context
Qingdao Vland Biotech INC appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Qingdao Vland Biotech INC is currently in a long term uptrend where the price is trading 3.6% above its 200 day moving average.
From a valuation standpoint, the stock is 59.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Qingdao Vland Biotech INC's total revenue rose by 17.5% to $261M since the same quarter in the previous year.
Its net income has increased by 90.6% to $29M since the same quarter in the previous year.
Finally, its free cash flow fell by 55.4% to $-31M since the same quarter in the previous year.
Based on the above factors, Qingdao Vland Biotech INC gets an overall score of 4/5.